Trial Profile
Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2023
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer; Solid tumours
- Focus Diagnostic use
- Acronyms BASKET PSMA
- 31 May 2023 Planned number of patients changed from 400 to 1200.
- 31 May 2023 Planned End Date changed from 1 Jul 2021 to 1 Jul 2023.
- 31 May 2023 Planned primary completion date changed from 1 Jul 2021 to 1 Jul 2023.